Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252122 · ClinicalTrials.gov registry record · Phase 4
Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease
A Phase 4 study, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT00252122: Clinical Trial Phase 4 study, sponsored by Children's Hospital of Philadelphia.
NCT00252122 is a Phase 4 study that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 3 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00252122, a Phase 4 study, was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to provide a preliminary assessment of the feasibility and efficacy of intravenous ketamine in controlling pain in patients with sickle cell disease (who are admitted to the hospital with severe, acute pain crisis, and who have been resistant to intravenous narcotics).
Interventions
- DRUG Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-06 |
| Est. Completion | 2007-01 |
| Phase | Phase 4 |
Why NCT00252122 stopped before completion
NCT00252122 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Ketamine is the first listed.
NCT00252122 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00252122 about?
NCT00252122 is a clinical study titled "Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease". The purpose of this pilot study is to provide a preliminary assessment of the feasibility and efficacy of intravenous ketamine in controlling pain in patients with sickle cell disease (who are admitted to the hospital with severe, acute pain crisis, and who have been resistant to intravenous narcoti...
What is the current status of trial NCT00252122?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2004-06. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00252122?
The interventions under investigation include: Ketamine (DRUG).
Who is sponsoring clinical trial NCT00252122?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00252122's enrollment target sits among peer trials
3 1995th of 2000 higher than 3 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia